The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2155-2160

  Wang, Lei ^a   Wang, Zhao Yi ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; MCF10AT3B cells; Proliferative breast disease; Tumor suppressor; WT1

Indexed keywords

TUMOR SUPPRESSOR PROTEIN; WT1 PROTEIN; ZINC FINGER PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CONTROLLED STUDY; EPITHELIUM TUMOR; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, WILMS TUMOR; HUMANS; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; WT1 PROTEINS;

EID: 49049101109     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, Koi M, Reeve AE, Brownstein BH, Yéger H, Williams BRG and Feingberg AP: Wilms' tumor locus on 11p13 defined by multiple CpG island associated transcripts. Science 250: 994-997, 1990.
2. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C and Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
3. Gessler M, Poutska A, Cavenee W, Neve RL, Orkin SH and Bruns GA: Homozygouse deletion in Wilms' tumors of a zinc finger gene identified by chromosome jumping. Nature (London) 343: 774-778, 1990.
4. Haber DA, Sohn L, Buckler AJ, Pelletier J, Call KM and Housman DE: Alternative splicing and genomic structure of the Wilms' tumor gene. Proc Natl Acad Sci USA 88: 9618-9622, 1991.
5. Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr and Daniel CW: Altered expression of the WT1 Wilms tumor suppressor gene in human breast. Proc Natl Acad Sci USA 94: 8132-8137, 1997.
6. Laux DE, Curran EM, Welshons WV, Lubahn DB and Huang TH: Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res Treat 56: 35-43, 1999.
7. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H and Lubahn DB: Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res 57: 1030-1034, 1997.
8. Zhang TF, Yu SQ, Guan LS and Wang ZY: Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of β-catenin. Anticancer Res 3: 35785-35874, 2003.
9. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D and Sukumar S: Wilms tumor suppressor (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 76: 921-925, 2001.
10. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H and Noguchi S: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167-1171, 2002.
11. Zapata-Benavides P, Tuna M, Lopez-Berestein G and Tari AM: Down-regulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295: 784-790, 2002.
12. Page DL and Dupont WD: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326-1335, 1990.
13. Dawaon PJ, Wolman SR, Tait L, Heppner GH and Miller FR: MCF10AT: A model for the evolution of cancer from proliferative breast disease. Am J Pathl 148: 313-319, 1996.
14. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ and Heppner GH: Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 85: 1725-1732, 1993.
15. Wang ZY, Zhang XT, Shen P, Loggie BW, Chang YC and Deuel TF: A variant of estrogen receptor-α, hER-α36: transduction of estrogen and anti-estrogen dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103: 9063-9068, 2006.
16. Page DL and Anderson TJ: Diagnostic Histopathology of the Breast. Edinburgh, UK, Churchill Livingstone, pp. 120-145, 1987.
17. Page DL, Dupont WD, Rogers LW and Rados MS: Atypical hyperplastic lesions of the female breast: along-term follow-up study. Cancer 55: 2698-2708, 1985.
18. Shekhar MPV, Chen ML, Werdell J, Heppner GH, Miller FR and Christman JK: Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol 13: 907-915, 1998.
19. Shekhar MPV, Nangia-Makker P, Wolman SR, Tait L, Heppner GH and Visscher DW: Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J of Pathl 152: 1129-1132, 1998.
20. Burwell EA, McCarty GP, Simpson LA, Thompson KA and Loeb DM: Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene 26: 3423-3430, 2006.
21. Englert C, Maheswaran SA, Garvin J, Kreidberg J and Haber DA: Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57: 1429-1434, 1997.
22. Resnitzky D and Reed SI: Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15: 3463-3469, 1995.
23. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge SJ, Nishimoto T, Morgan DO, Franza BR and Roberts JM: Formation and activation of a cyclin E-cdk2 complex during the G1-phase of the human cell cycle. Science 257: 1689-1694, 1992.
24. Clurman BE, Sheaff RJ, Thress K, Groudine M and Roberts JM: Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10: 1979-1990, 1996.